Oscar Health, Inc. (NYSE:OSCR) Stock Rated “Hold” by Sell-Side Brokerages

Oscar Health, Inc. (NYSE:OSCR) has earned a consensus recommendation of “Hold” from the thirteen research firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $34.90.

OSCR has been the topic of several analyst reports. Weiss Ratings upgraded shares of Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. The Goldman Sachs Group restated a “neutral” rating and set a $34.00 price objective on shares of Oscar Health in a research report on Thursday, September 17th. Stephens restated an “equal weight” rating and set a $34.00 price objective on shares of Oscar Health in a research report on Thursday, September 17th. UBS Group upped their target price on Oscar Health from $26.00 to $36.00 and gave the stock a “neutral” rating in a research note on Monday, October 12th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $48.00 target price on shares of Oscar Health in a report on Thursday, September 17th.

Insider Activity at Oscar Health

In related news, CFO Richard Blackley sold 28,869 shares of the company’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $907,930.05. Following the completion of the sale, the chief financial officer directly owned 1,046,108 shares in the company, valued at $32,900,096.60. This represents a 2.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 600,000 shares of the firm’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $30.34, for a total value of $18,204,000.00. Following the completion of the sale, the director directly owned 480,866 shares in the company, valued at $14,589,474.44. This trade represents a 55.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 874,451 shares of company stock worth $26,761,671 in the last three months. Insiders own 22.64% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Tidal Investments LLC bought a new position in shares of Oscar Health in the 2nd quarter valued at $2,240,000. Convergence Investment Partners LLC acquired a new stake in shares of Oscar Health during the 1st quarter valued at $1,208,000. Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new stake in shares of Oscar Health during the 1st quarter valued at $1,297,000. Wellington Management Group LLP grew its position in Oscar Health by 65.6% during the 2nd quarter. Wellington Management Group LLP now owns 603,675 shares of the company’s stock worth $17,217,000 after acquiring an additional 239,109 shares during the last quarter. Finally, Genesee Capital Advisors LLC grew its position in Oscar Health by 227.8% during the 3rd quarter. Genesee Capital Advisors LLC now owns 44,338 shares of the company’s stock worth $1,367,000 after acquiring an additional 30,814 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Trading Down 3.1%

OSCR opened at $30.39 on Friday. The stock has a market capitalization of $9.38 billion, a price-to-earnings ratio of 21.71, a P/E/G ratio of 0.34 and a beta of 2.47. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health has a twelve month low of $10.69 and a twelve month high of $35.01. The company has a 50-day simple moving average of $31.74 and a 200 day simple moving average of $23.45.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $0.40 by $0.70. The firm had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business’s quarterly revenue was up 70.4% compared to the same quarter last year. During the same period last year, the firm earned ($0.89) EPS. Analysts predict that Oscar Health will post 1.83 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.